Pakistan has partnered with Medecins Sans Frontieres (MSF) to strengthen the country's response to childhood tuberculosis (TB). The collaboration aims to enhance early detection, improve treatment outcomes, and reduce mortality among children affected by TB.
Key Initiatives
The joint effort focuses on several critical areas, including training healthcare workers, upgrading diagnostic facilities, and ensuring access to child-friendly TB medications. MSF will provide technical expertise and support to integrate childhood TB services into existing health systems.
Addressing Diagnostic Gaps
One of the major challenges in combating childhood TB is the lack of accurate diagnostic tools. The partnership will introduce advanced molecular testing and chest X-ray interpretation for children, helping to identify cases earlier. Community health workers will also be trained to recognize TB symptoms in children and refer them for testing.
Treatment and Care
Child-friendly formulations of TB drugs will be made more widely available, and treatment adherence will be supported through family-centered care models. The initiative also includes nutritional support for children undergoing TB treatment, as malnutrition is a common comorbidity.
Impact and Goals
Pakistan ranks among the top five countries with the highest TB burden globally, with children accounting for a significant proportion of cases. The MSF partnership aims to reduce childhood TB deaths by 50% in targeted districts over the next three years. Additionally, the program will generate evidence to inform national policies and scale up interventions.
Dr. Ayesha Khan, a TB specialist at MSF, emphasized the importance of the collaboration: "Childhood TB has been neglected for too long. By working together, we can ensure that no child dies from a preventable and curable disease."
The initiative aligns with Pakistan's National TB Control Program and the global End TB Strategy, which seeks to eliminate TB by 2030.
